Orchestra BioMed Holdings, Inc. (OBIO) Insider Trading

Last 12 months

Insiders bought $280k and sold $353k on the open market.

All of the selling was scheduled in advance under 10b5-1 plans.

Net open-market

−$73k

9 buys · 5 sales

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

4 / 1

executives and directors

Last open-market buy

Sep 2026

Sep 3, 2026

Get an email when OBIO's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 1	Darren Sherman See Remarks	Sold10b5-1 plan	15,000	$6.36	$95k	1.3%	Form 4
Sep 3	David P Hochman See Remarks	Bought	10,000	$4.79	$48k	0.7%	Form 4
Sep 1	Darren Sherman See Remarks	Sold10b5-1 plan	15,000	$4.94	$74k	1.3%	Form 4
Aug 26	Darren Sherman See Remarks	Bought	2,000	$5.33	$11k	0.2%	Form 4
Aug 3	Darren Sherman See Remarks	Sold10b5-1 plan	15,000	$4.09	$61k	1.3%	Form 4
Jul 1	Darren Sherman See Remarks	Sold10b5-1 plan	15,000	$4.27	$64k	1.3%	Form 4
Jun 1	David P Hochman See Remarks	Bought	5,000	$3.83	$19k	0.3%	Form 4
Jun 1	Darren Sherman See Remarks	Sold10b5-1 plan	15,000	$3.87	$58k	1.3%	Form 4
May 18	Jason Aryeh Director	Bought	665	$3.75	$2k	0.6%	Form 4
May 15	Jason Aryeh Director	Bought	8,971	$3.90	$35k	8.3%	Form 4
May 15	David P Hochman See Remarks	Bought	5,000	$3.77	$19k	0.3%	Form 4
May 14	Eric S Fain Director	Bought	20,000	$4.13	$83k	28%	Form 4
Apr 27	RTW Investments, LP Large holder	SoldNo plan	32	$4.13	$132	<0.1%	Form 4
Mar 13	David P Hochman See Remarks	Bought	10,000	$4.29	$43k	0.7%	Form 4
Nov 14, 2025	David P Hochman See Remarks	Bought	5,000	$4.07	$20k	0.5%	Form 4
Sep 19, 2025	Jason Aryeh Director	Bought	1,000	$2.45	$2k	0.9%	Form 4
Aug 25, 2025	Eric S Fain Director	Bought	5,760	$2.61	$15k	8.7%	Form 4
Aug 25, 2025	Darren Sherman See Remarks	Bought	3,000	$2.62	$8k	0.3%	Form 4
Aug 25, 2025	Andrew Lawrence Taylor Chief Financial Officer	Bought	2,000	$2.55	$5k	0.4%	Form 4
Aug 21, 2025	David P Hochman See Remarks	Bought	6,000	$2.49	$15k	0.5%	Form 4
Aug 4, 2025	David P Hochman See Remarks	Bought	20,000	$2.75	$55k	2.3%	Form 4
Aug 1, 2025	Perceptive Life Sciences Master Fund LTD Large holder	Bought	700,000	$2.75	$1.93M	15%	Form 4
Jun 26, 2025	Eric S Fain Director	SoldNo plan	2,683	$3.05	$8k	5.0%	Form 4
Apr 30, 2025	Roderick Wong Large holder	Bought	49,900	$2.99	$149k	0.6%	Form 4
Apr 29, 2025	RTW Investments, LP Large holder	Bought	50,000	$2.53	$127k	0.6%	Form 4
Dec 23, 2024	David P Hochman See Remarks	Bought	4,000	$4.66	$19k	0.4%	Form 4
Dec 19, 2024	Andrew Lawrence Taylor Chief Financial Officer	Bought	1,000	$4.83	$5k	0.3%	Form 4
Dec 18, 2024	David P Hochman See Remarks	Bought	5,000	$4.91	$25k	0.5%	Form 4

Oct 110b5-1 plan
Darren Sherman
See Remarks · sold 15,000 at $6.36
$95k
1.3% of stake
Sep 3
David P Hochman
See Remarks · bought 10,000 at $4.79
$48k
0.7% of stake
Sep 110b5-1 plan
Darren Sherman
See Remarks · sold 15,000 at $4.94
$74k
1.3% of stake
Aug 26
Darren Sherman
See Remarks · bought 2,000 at $5.33
$11k
0.2% of stake
Aug 310b5-1 plan
Darren Sherman
See Remarks · sold 15,000 at $4.09
$61k
1.3% of stake
Jul 110b5-1 plan
Darren Sherman
See Remarks · sold 15,000 at $4.27
$64k
1.3% of stake
Jun 1
David P Hochman
See Remarks · bought 5,000 at $3.83
$19k
0.3% of stake
Jun 110b5-1 plan
Darren Sherman
See Remarks · sold 15,000 at $3.87
$58k
1.3% of stake
May 18
Jason Aryeh
Director · bought 665 at $3.75
$2k
0.6% of stake
May 15
Jason Aryeh
Director · bought 8,971 at $3.90
$35k
8.3% of stake
May 15
David P Hochman
See Remarks · bought 5,000 at $3.77
$19k
0.3% of stake
May 14
Eric S Fain
Director · bought 20,000 at $4.13
$83k
28% of stake
Apr 27No plan
RTW Investments, LP
Large holder · sold 32 at $4.13
$132
<0.1% of stake
Mar 13
David P Hochman
See Remarks · bought 10,000 at $4.29
$43k
0.7% of stake
Nov 14, 2025
David P Hochman
See Remarks · bought 5,000 at $4.07
$20k
0.5% of stake
Sep 19, 2025
Jason Aryeh
Director · bought 1,000 at $2.45
$2k
0.9% of stake
Aug 25, 2025
Eric S Fain
Director · bought 5,760 at $2.61
$15k
8.7% of stake
Aug 25, 2025
Darren Sherman
See Remarks · bought 3,000 at $2.62
$8k
0.3% of stake
Aug 25, 2025
Andrew Lawrence Taylor
Chief Financial Officer · bought 2,000 at $2.55
$5k
0.4% of stake
Aug 21, 2025
David P Hochman
See Remarks · bought 6,000 at $2.49
$15k
0.5% of stake
Aug 4, 2025
David P Hochman
See Remarks · bought 20,000 at $2.75
$55k
2.3% of stake
Aug 1, 2025
Perceptive Life Sciences Master Fund LTD
Large holder · bought 700,000 at $2.75
$1.93M
15% of stake
Jun 26, 2025No plan
Eric S Fain
Director · sold 2,683 at $3.05
$8k
5.0% of stake
Apr 30, 2025
Roderick Wong
Large holder · bought 49,900 at $2.99
$149k
0.6% of stake
Apr 29, 2025
RTW Investments, LP
Large holder · bought 50,000 at $2.53
$127k
0.6% of stake
Dec 23, 2024
David P Hochman
See Remarks · bought 4,000 at $4.66
$19k
0.4% of stake
Dec 19, 2024
Andrew Lawrence Taylor
Chief Financial Officer · bought 1,000 at $4.83
$5k
0.3% of stake
Dec 18, 2024
David P Hochman
See Remarks · bought 5,000 at $4.91
$25k
0.5% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch OBIO, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Surgical & Medical Instruments & Apparatus

PREMPremier Air Charter Holdings Inc.

SSKNStrata Skin Sciences Inc.

IDXGInterpace Biosciences Inc.

DYNTQDynatronics Corp

RVPRetractable Technologies Inc.

CTSOCytosorbents Corporation

UTMDUtah Medical Products Inc.

SRTSSensus Healthcare Inc.

Spot a number that looks wrong? Check it in OBIO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing OBIO

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.